DE69032537D1 - Verbindungen zur Behandlung von Bauchentzündungen - Google Patents

Verbindungen zur Behandlung von Bauchentzündungen

Info

Publication number
DE69032537D1
DE69032537D1 DE69032537T DE69032537T DE69032537D1 DE 69032537 D1 DE69032537 D1 DE 69032537D1 DE 69032537 T DE69032537 T DE 69032537T DE 69032537 T DE69032537 T DE 69032537T DE 69032537 D1 DE69032537 D1 DE 69032537D1
Authority
DE
Germany
Prior art keywords
benzyl
connections
treatment
rhodanine derivatives
substituted rhodanine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69032537T
Other languages
English (en)
Other versions
DE69032537T2 (de
Inventor
Jaswant Singh Gidda
Jill Ann Panetta
Michael Leroy Phillips
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of DE69032537D1 publication Critical patent/DE69032537D1/de
Publication of DE69032537T2 publication Critical patent/DE69032537T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/36—Sulfur atoms
DE69032537T 1989-12-21 1990-12-19 Verbindungen zur Behandlung von Bauchentzündungen Expired - Fee Related DE69032537T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45420389A 1989-12-21 1989-12-21

Publications (2)

Publication Number Publication Date
DE69032537D1 true DE69032537D1 (de) 1998-09-10
DE69032537T2 DE69032537T2 (de) 1999-01-21

Family

ID=23803709

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69032537T Expired - Fee Related DE69032537T2 (de) 1989-12-21 1990-12-19 Verbindungen zur Behandlung von Bauchentzündungen

Country Status (22)

Country Link
EP (1) EP0434394B1 (de)
JP (1) JP3036853B2 (de)
KR (1) KR0176243B1 (de)
CN (1) CN1029846C (de)
AT (1) ATE169294T1 (de)
AU (1) AU639734B2 (de)
CA (1) CA2032330C (de)
CY (1) CY2100B1 (de)
DE (1) DE69032537T2 (de)
DK (1) DK0434394T3 (de)
ES (1) ES2121748T3 (de)
FI (2) FI104251B1 (de)
HU (1) HU216732B (de)
IE (1) IE904633A1 (de)
IL (3) IL108962A (de)
MX (1) MX23803A (de)
NO (1) NO300458B1 (de)
NZ (1) NZ236472A (de)
PT (1) PT96198B (de)
RU (2) RU2036915C1 (de)
YU (1) YU240690A (de)
ZA (1) ZA9010041B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU87339A1 (fr) * 1988-09-20 1990-04-06 Oreal Nouveaux derives de benzylidene-cyclanones,leur procede de preparation,leur utilisation en tant qu'agents anti-oxydants et comme filtres solaires,compositions cosmetiques et pharmaceutiques les contenant
US5143928A (en) * 1990-03-27 1992-09-01 Warner-Lambert Company 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
NZ248573A (en) * 1992-09-10 1996-02-27 Lilly Co Eli 5-arylmethyl (and methylidene) thiazolidin-4-one derivatives; their preparation and pharmaceutical compositions
DE69301894T2 (de) * 1992-10-28 1996-11-07 Shionogi & Co Benzylidenderivate
US6251928B1 (en) 1994-03-16 2001-06-26 Eli Lilly And Company Treatment of alzheimer's disease employing inhibitors of cathepsin D
US5563277A (en) * 1994-12-21 1996-10-08 Eli Lilly And Company Process for preparing benzyl-substituted rhodanine derivatives
SI0761657T1 (en) * 1995-09-07 2000-10-31 Eli Lilly And Company Process for preparing benzyl-substituted rhodanine derivatives
AR003483A1 (es) * 1995-09-07 1998-08-05 Lilly Co Eli Procedimiento para preparar y aislar la forma ii de la (±)-5-[3,5-bis(1,1- dimetil)-4-hidroxifenil)-metil)-4-tiazolidinona.
EP0779282A1 (de) * 1995-12-14 1997-06-18 Eli Lilly And Company Thiomorpholinon-Verbindungen zur Behandlung von Multiple-Sklerose
US5981523A (en) * 1996-02-05 1999-11-09 Eli Lilly And Company Compounds and methods for treating multiple sclerosis
US6005142A (en) * 1996-09-03 1999-12-21 Eli Lilly And Company Process for preparing benzyl-substituted rhodanine derivatives
US6063799A (en) * 1996-09-03 2000-05-16 Eli Lilly And Company Alternate crystal form of Tazofelone
WO2000018748A1 (en) * 1998-09-30 2000-04-06 Roche Diagnostics Gmbh Rhodanine derivatives for the treatment and prevention of metabolic bone disorders
AU6331099A (en) * 1998-09-30 2000-04-17 Roche Diagnostics Gmbh Thiazolidine derivatives for the treatment and prevention of metabolic bone disorders
US6673816B1 (en) 1998-09-30 2004-01-06 Angelika Esswein Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders
US7235573B2 (en) 2002-09-30 2007-06-26 The Regents Of The University Of California Methods of treating secretory diarrhea using cystic fibrosis transmembrane conductance regulator protein inhibitors
JP4977319B2 (ja) * 2002-09-30 2012-07-18 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 嚢胞性線維症膜コンダクタンス制御因子蛋白質阻害薬およびその使用方法
AU2002953533A0 (en) 2002-12-24 2003-01-16 Arthron Limited Fc receptor modulating compounds and compositions
AU2011240367B2 (en) * 2010-04-15 2015-07-16 Merck Patent Gmbh Process for the preparation of hydroquinones

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1285572C (en) * 1985-08-09 1991-07-02 Jill Ann Panetta Di-t-butylphenol compounds
IE940525L (en) * 1988-05-25 1989-11-25 Warner Lambert Co Known and selected novel arylmethylenyl derivatives of¹thiazolidinones, imidazolidinones and oxazolidinones useful¹as antiallergy agents and antiinflammatory agents
ZA902520B (en) * 1989-04-07 1991-12-24 Lilly Co Eli Aryl-substituted rhodanine derivatives

Also Published As

Publication number Publication date
FI19991698A (fi) 1999-08-10
EP0434394A3 (en) 1992-01-08
HU908368D0 (en) 1991-07-29
HU216732B (hu) 1999-08-30
ATE169294T1 (de) 1998-08-15
HUT59915A (en) 1992-07-28
EP0434394B1 (de) 1998-08-05
CA2032330C (en) 2001-05-08
KR910011812A (ko) 1991-08-07
MX23803A (es) 1994-02-28
IL96654A (en) 1995-06-29
CN1029846C (zh) 1995-09-27
FI906273A0 (fi) 1990-12-19
FI104251B (fi) 1999-12-15
RU2036915C1 (ru) 1995-06-09
JPH04279573A (ja) 1992-10-05
AU6826690A (en) 1991-06-27
KR0176243B1 (ko) 1999-03-20
ZA9010041B (en) 1992-08-26
FI104251B1 (fi) 1999-12-15
FI906273A (fi) 1991-06-22
PT96198B (pt) 1998-05-29
DE69032537T2 (de) 1999-01-21
NO300458B1 (no) 1997-06-02
EP0434394A2 (de) 1991-06-26
AU639734B2 (en) 1993-08-05
YU240690A (sh) 1992-12-21
DK0434394T3 (da) 1998-12-14
NO905478L (no) 1991-06-24
PT96198A (pt) 1991-09-30
RU2050355C1 (ru) 1995-12-20
IL108962A (en) 1996-12-05
NZ236472A (en) 1993-03-26
CY2100B1 (en) 2002-04-05
CN1052668A (zh) 1991-07-03
ES2121748T3 (es) 1998-12-16
IL108962A0 (en) 1994-06-24
IE904633A1 (en) 1991-07-17
JP3036853B2 (ja) 2000-04-24
CA2032330A1 (en) 1991-06-22
NO905478D0 (no) 1990-12-19

Similar Documents

Publication Publication Date Title
DE69032537D1 (de) Verbindungen zur Behandlung von Bauchentzündungen
ATE79544T1 (de) Zusammensetzungen zur behandlung von hypercholesterinaemie.
ATE174027T1 (de) Heterozyklische verbindungen, ihre herstellung und anwendung
DE69011951D1 (de) Verfahren zur Behandlung und Herstellung von Material.
HU902115D0 (en) Process for producing aryl-substituted rhodanide deriatives
DE3676922D1 (de) Neue polyoxygenierte labdan-derivate, verfahren zu ihrer herstellung und ihre anwendung als medikamente.
AT383123B (de) Verfahren zur herstellung von neuen (+)-catechin- alpha- monohydrat
DE69130679D1 (de) Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation
ATE81118T1 (de) Strontiumsalz, verfahren zu dessen herstellung und arzneimittel, die es enthalten.
DE3775496D1 (de) Benzhydryloxyaethyl-piperidine-derivate, verfahren zur herstellung und pharmazeutische zusammenstellungen, die diese enthalten.
DE69527802T2 (de) Verfahren zur herstellung von benzyl-substituierten rhodanin derivaten
PT70560A (de) 1,3,4-thiadiazol-2-carbonsaure-derivate verfahren zur herstellung dieser verbindungen sowie diese enthaltende fungizide und nematizide mittel
NO950952D0 (no) Fremgangsmåte for fremstilling av pilokarpin
HUT57749A (en) Process for producing pharmaceutical compositions suitable for treating pathological conditions concerning cerebral blood insufficiency and one special active ingredient
ATE163424T1 (de) Neue 17-(3-imino-2-alkyl-propenyl)-5beta-14beta- androstanderivate, zur behandlung von kardiovaskulären erkrankungen, ein verfahren zu ihrer herstellung und pharmazeutische präparate davon
ATE196085T1 (de) Verfahren und zusammensetzung zur behandlung von infektionen unter verwendung von optisch reinem (r) - lomefloxacin

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee